Parkinson’s disease: FDA approves Nourianz as an add-on treatment
The U.S. Food and Drug Administration today approved Nourianz (istradefylline) tablets as an add-on treatment to levodopa/carbidopa in adult patients with Parkinson’s disease (PD) experiencing “off” More...
NFL Players’ $1 Billion Concussion Settlement Put on Hold by Appeal
A proposed $1 billion settlement to the NFL players’ concussion lawsuit is headed to the Supreme Court to answer questions about distribution of the settlement posed by one former player’s family. The family More...
Marshall University scientists develop a new approach for Parkinson’s disease therapy
Last year, Dr. Elmer Price, a professor of biological sciences at Marshall University, was awarded a three-year, $350,000 research grant from the National Science Foundation. The grant funds his research into understanding More...
Parkinson’s disease: Six new genetic risk factors discovered
Using data from over 18,000 patients, scientists have identified more than two dozen genetic risk factors involved in Parkinson’s disease, including six that had not been previously reported. The study, published More...
